CliffBio
small molecule

OMECLAMOX-PAK

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE

Loss of exclusivity—loss of exclusivity
CompanyCumberland →See this company's full patent-cliff portfolio

Drug detail

Brand nameOMECLAMOX-PAK
Active ingredientAMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE
Strength500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formCAPSULE, TABLET, CAPSULE, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2011
Marketing statusDISCN

More from Cumberland

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

OMECLAMOX-PAK patent cliff — loss of exclusivity — | CliffBio